EUVIMEDEUVIMED entdecken
Crossref

Vitamin D attenuates elevated oxidative DNA damage in scleroderma patients with organ involvement: A prospective study

Nazlı Ecem Dal-Bekar, Gül Hüray İşlekel, Aydan Köken-Avşar, Handan Yarkan-Tuğsal, Gamze Tuna, Berrin Zengin, Ahmet Merih Birlik

The Journal of Steroid Biochemistry and Molecular Biology · 2023

DOI: 10.1016/j.jsbmb.2023.106273 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Steroid Biochemistry and Molecular Biology, 2023. Verfasst von Nazlı Ecem Dal-Bekar und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dokuz Eylül University, Institute of Health Sciences, Department of Molecular Medicine, Izmir, Turkey; Izmir University of Economics, Faculty of Medi…. Hauptthemen laut MEDLINE: Vitamin D, Genetic Predisposition to Disease. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Dokuz Eylül Üniversitesi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Scleroderma is a rare autoimmune disease characterized by progressive fibrosis of the skin and internal organs. Oxidative damage to macromolecules has been reported to occur in scleroderma. Among the macromolecular damages, oxidative DNA damage is a sensitive and cumulative marker of oxidative stress and is of particular interest because of its cytotoxic and mutagenic effects. Vitamin D supplementation is an important part of treatment, as vitamin D deficiency is a common problem in scleroderma. Furthermore, the antioxidant role of vitamin D has been demonstrated in recent studies. In light of this information, the present study aimed to comprehensively investigate oxidative DNA damage in scleroderma at baseline and to evaluate the contribution of vitamin D supplementation to the attenuation of DNA damage in a prospectively designed study. In accordance with these objectives, oxidative DNA damage in scleroderma was evaluated by measurement of stable damage products (8-oxo-dG, S-cdA, and R-cdA) in urine by liquid chromatography-tandem mass spectrometry (LC-MS/MS); serum vitamin D levels were determined by high-resolution mass spectrometry (HR-MS); VDR gene expression and four polymorphisms in the VDR gene (rs2228570, rs1544410, rs7975232, and rs731236) were analyzed by RT-PCR and compared with healthy subjects. In the prospective part, the DNA damage and the VDR expression of the patients who received vitamin D were re-evaluated after the replacement. As a result of this study, we demonstrated that all DNA damage products were increased in scleroderma patients compared to healthy controls, whereas vitamin D levels and VDR expression were significantly lower (p < 0.05). After supplementation, statistical significance (p < 0.05) was reached for the decrease in 8-oxo-dG and the increase in VDR expression. Attenuated 8-oxo-dG after replacement in patients with lung, joint, and gastrointestinal system involvement demonstrated the efficacy of vitamin D in scleroderma patients with organ involvement. To the best of our knowledge, this is the first study to examine oxidative DNA damage in scleroderma comprehensively and to evaluate the effects of vitamin D on DNA damage using a prospective design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin DGenetic Predisposition to DiseaseHumansProspective Studies8-Hydroxy-2'-DeoxyguanosineChromatography, LiquidReceptors, CalcitriolTandem Mass SpectrometryVitaminsOxidative StressPolymorphism, Single NucleotideCase-Control StudiesGenotype

Stichwörter der Autor:innen

Mass spectrometryOxidative DNA damageSystemic sclerosisVitamin DVitamin D receptor

Substanzen

Vitamin D8-Hydroxy-2'-DeoxyguanosineReceptors, CalcitriolVitamins

Autor:innen und Institutionen

  • Dokuz Eylül University, Institute of Health Sciences, Department of Molecular Medicine, Izmir, Turkey; Izmir University of Economics, Faculty of Medicine, Department of Medical Biochemistry, Izmir, Turkey. Electronic ad…
  • Dokuz Eylül University, Institute of Health Sciences, Department of Molecular Medicine, Izmir, Turkey; Dokuz Eylül University, Faculty of Medicine, Department of Medical Biochemistry, Izmir, Turkey.
  • Dokuz Eylül University, Faculty of Medicine, Department of Immunology and Rheumatology, Izmir, Turkey; Kocaeli State Hospital, Department of Rheumatology, Izmit, Turkey.
  • Ankara Training and Research Hospital, Department of Rheumatology, Ankara, Turkey.
  • Dokuz Eylül University, Institute of Health Sciences, Department of Molecular Medicine, Izmir, Turkey.
  • Dokuz Eylül University, Faculty of Medicine, Department of Immunology and Rheumatology, Izmir, Turkey; Izmir Bozyaka Training and Research Hospital, Department of Rheumatology, Izmir, Turkey.

Förderung

  • Dokuz Eylül Üniversitesi

Zitieren

APA

Dal-Bekar, N. E., İşlekel, G. H., Köken-Avşar, A., Yarkan-Tuğsal, H., Tuna, G., Zengin, B., & Birlik, A. M. (2023). Vitamin D attenuates elevated oxidative DNA damage in scleroderma patients with organ involvement: A prospective study. The Journal of Steroid Biochemistry and Molecular Biology. https://doi.org/10.1016/j.jsbmb.2023.106273

Vancouver

Dal-Bekar NE, İşlekel GH, Köken-Avşar A, Yarkan-Tuğsal H, Tuna G, Zengin B, et al. Vitamin D attenuates elevated oxidative DNA damage in scleroderma patients with organ involvement: A prospective study. The Journal of Steroid Biochemistry and Molecular Biology. 2023. doi:10.1016/j.jsbmb.2023.106273

BibTeX
@article{DalBekar2023,
  author = {Dal-Bekar, Nazlı Ecem and İşlekel, Gül Hüray and Köken-Avşar, Aydan and Yarkan-Tuğsal, Handan and Tuna, Gamze and Zengin, Berrin and Birlik, Ahmet Merih},
  title = {Vitamin D attenuates elevated oxidative DNA damage in scleroderma patients with organ involvement: A prospective study},
  journal = {The Journal of Steroid Biochemistry and Molecular Biology},
  year = {2023},
  doi = {10.1016/j.jsbmb.2023.106273}
}
Kostenlos starten →